Regional Blood Saturation Levels in Gastroschisis
Regional Haemoglobin Oxygen Saturation in the Splanchnic Circulation in Neonates With Gastroschisis; Quantifying and Qualifying the Role for Routine Monitoring
1 other identifier
observational
19
0 countries
N/A
Brief Summary
Gastroschisis is one of the most common neonatal surgical conditions, and is increasing in incidence. Postnatal bowel ischemia leading to necrosis, bowel loss and short-bowel syndrome, occurs in a few instances, with significant impact. Intestinal gangrene occurs in up to 37%. The cause of the gangrene can be multifactorial. Contributing factors can be volvulus; venous engorgement with ensuing arterial compromise; constriction of the gut mesentery at the defect; and contribution of the hydrostatic effect of the column of bowel within a silo. Theoretically, the increased hydrostatic pressure incurred by the bowel in a preformed silo, may decrease blood flow to the apex of the bowel and contribute to ischemia. However, this does not seem to be the norm, as most cases do well in the silo. Cases of intestinal ischaemia within the silo have been described in patients. Any objective measure of bowel perfusion and therefore viability which can aid clinical assessment and management may benefit patient outcome. Near-infrared spectroscopy (NIRS) is used to noninvasively measure and monitor changes in the approximate regional haemoglobin oxygen saturation (SO2) in the blood. Measurement of oxygen saturation using NIRS is already in clinical application in other neonatal and paediatric medical and surgical diseases. NIRS has been recommended as a good trend indicator of changes in neonatal tissues oxygenation. NIRS-measured duration of cerebral oxygen desaturation is an accurate predictor of postoperative neurological injury in children undergoing cardiac surgery. The investigators propose to use NIRS to measure SO2 in the intestinal bed in patients with gastroschisis and to ascertain if there is any clinical advantage to routine monitoring in these patients. The aim of the study will be to:
- 1.Measure Gastrointestinal SO2 (GSO2) of the bowel within the silo of gastroschisis patients
- 2.Identify the clinical progress of patients with gastroschisis in the postnatal period
- 3.Identify any association of the measured GSO2 with the clinical outcome and any gastrointestinal complications
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2017
CompletedFirst Submitted
Initial submission to the registry
April 23, 2018
CompletedFirst Posted
Study publicly available on registry
May 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedSeptember 23, 2024
January 1, 2018
3.9 years
April 23, 2018
September 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of intestinal ischemia requiring intervention and its correlation to measured GSO2
Through study completion, an average of 6 weeks
Secondary Outcomes (2)
Time to full feeds
Through study completion, an average of 6 weeks
Changes in renal oxygenation measured by near infra-red spectroscopy
Through study completion, an average of 6 weeks
Interventions
Four channel measurement of regional haemoglobin oxygen saturation (SO2) in the blood of the bowel, kidney and brain of neonates with gastroschisis during reduction within a silo and after surgery will be performed.• Routine surgical procedure will be followed (clinically indicated silo placement and closure as is currently practised). There will be no change in the clinical practice in place during this pilot study. Clinical management will be as already practiced with the supervision of the consultant with clinical responsibility dictating management
Eligibility Criteria
Newborn babies at neonatal unit
You may qualify if:
- Gastroschisis diagnosed antenatally or at birth
You may not qualify if:
- Associated congenital condition affecting respiratory system , cardiovascular system or global development
- Generalised sepsis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Lothianlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merrill McHoney, PhD
NHS Lothian
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2018
First Posted
May 23, 2018
Study Start
October 15, 2013
Primary Completion
August 31, 2017
Study Completion
July 1, 2018
Last Updated
September 23, 2024
Record last verified: 2018-01